We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 882 results
  1. Ferrozoles: Ferrocenyl derivatives of letrozole with dual effects as potent aromatase inhibitors and cytostatic agents

    In the treatment of hormone-dependent cancers, aromatase inhibitors (AI) are receiving increased attention due to some undesirable effects such as...

    Borja Diaz de Greñu, Diego M. Fernández-Aroca, ... Blanca R. Manzano in JBIC Journal of Biological Inorganic Chemistry
    Article 17 July 2023
  2. SERPINA3-ANKRD11-HDAC3 pathway induced aromatase inhibitor resistance in breast cancer can be reversed by HDAC3 inhibition

    Endocrine resistance is a major challenge for breast cancer therapy. To identify the genes pivotal for endocrine-resistance progression, we screened...

    **g Zhou, Mengdi Zhu, ... Qiang Liu in Communications Biology
    Article Open access 06 July 2023
  3. Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors

    Bone-active drugs are recommended to protect the skeleton from detrimental actions of aromatase inhibitors (AIs). However, most of literature data...

    Gherardo Mazziotti, Rebecca Pedersini, ... Alfredo Berruti in Calcified Tissue International
    Article 28 July 2022
  4. Regulation of aromatase in cancer

    The regulation of aromatase, an enzyme involved in the biosynthesis of estrogen in normal and cancer cells, has been associated with growth factor...

    Deborah Molehin, Fahmida Rasha, ... Kevin Pruitt in Molecular and Cellular Biochemistry
    Article 18 February 2021
  5. Type I IFN stimulates IFI16-mediated aromatase expression in adipocytes that promotes E2-dependent growth of ER-positive breast cancer

    Although type I interferons (IFNs) play multifaceted roles during tumorigenesis and cancer treatment, the interplay between type I IFNs and estrogen...

    Na-Lee Ka, Ga Young Lim, ... Mi-Ock Lee in Cellular and Molecular Life Sciences
    Article Open access 20 May 2022
  6. FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway

    CDK4/6 inhibitors are routinely recommended agents for the treatment of advanced HR + HER2 breast cancer. However, their therapeutic effectiveness in...

    Guanglei Chen, Lisha Sun, ... Caigang Liu in Science China Life Sciences
    Article 14 July 2023
  7. Virtual screening for potential discoidin domain receptor 1 (DDR1) inhibitors based on structural assessment

    Discoidin domain receptor 1 (DDR1) (EC Number 2.7.10.1) has recently been considered as a promising therapeutic target for idiopathic pulmonary...

    Jiali **e, Dan Meng, ... ** Deng in Molecular Diversity
    Article 02 November 2022
  8. Aging is associated with sex-specific alteration in the expression of genes encoding for neuroestradiol synthesis and signaling proteins in the mouse trigeminal somatosensory input

    Pain perception is influenced by sex and aging, with previous studies indicating the involvement of aromatase, the estradiol synthase enzyme, in...

    Álvaro Bautista-Abad, Nuria García-Magro, ... Daniela Grassi in GeroScience
    Article Open access 02 July 2024
  9. Anti-masculinization induced by aromatase inhibitors in adult female zebrafish

    Background

    Early sex differentiation genes of zebrafish remain an unsolved mystery due to the difficulty to distinguish the sex of juvenile zebrafish....

    Lu Chen, Li Wang, ... Zhen-**a Chen in BMC Genomics
    Article Open access 07 January 2020
  10. In silico analysis of nsSNPs in CYP19A1 gene affecting breast cancer associated aromatase enzyme

    The human aromatase protein encoded by CYP19A1 gene is the principle enzyme involved in the biogenesis of oestrogen in adipose tissues. An excessive...

    Honey Pavithran, Ranjith Kumavath in Journal of Genetics
    Article 28 April 2021
  11. Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors

    Alpelisib is a selective inhibitor of phosphoinositide 3-kinase (PI3K)α, shown to improve outcomes for PIK3CA -mutant, hormone receptor–positive...

    Pedram Razavi, Maura N. Dickler, ... Sarat Chandarlapaty in Nature Cancer
    Article 23 March 2020
  12. Identification of bicyclic compounds that act as dual inhibitors of Bcl-2 and Mcl-1

    Elevated expression of anti-apoptotic proteins, such as Bcl-2 and Mcl-1 contributes to poor prognosis and resistance to current treatment modalities...

    Abhay Uthale, Aarti Anantram, ... Tanuja Teni in Molecular Diversity
    Article 31 July 2022
  13. An in-silico scaffold- hop** approach to design novel inhibitors against gp130: A potential therapeutic application in cancer and Covid-19

    An upregulation of the gp130-signalling cascade has been reported in multiple cancers, making gp130 an attractive target for the development of...

    Alankar Roy, Ishani Paul, ... Sujay Ray in Molecular Diversity
    Article 07 November 2023
  14. The present and future of PI3K inhibitors for cancer therapy

    Phosphoinositide 3-kinase (PI3K) signaling regulates cellular proliferation, survival and metabolism, and its aberrant activation is one of the most...

    Pau Castel, Eneda Toska, ... Maurizio Scaltriti in Nature Cancer
    Article 17 June 2021
  15. Single-cell morphological and transcriptome analysis unveil inhibitors of polyploid giant breast cancer cells in vitro

    Considerable evidence suggests that breast cancer therapeutic resistance and relapse can be driven by polyploid giant cancer cells (PGCCs). The...

    Mengli Zhou, Yushu Ma, ... Yu-Chih Chen in Communications Biology
    Article Open access 21 December 2023
  16. Steroidal ferrocenes as potential enzyme inhibitors of the estrogen biosynthesis

    The potential inhibitory effect of diverse triazolyl-ferrocene steroids on key enzymes of the estrogen biosynthesis was investigated. Test compounds...

    Bianka Edina Herman, János Gardi, ... Mihály Szécsi in Biologia Futura
    Article Open access 25 June 2020
  17. Fungal aromatic-bisabolane sesquiterpenoids—possible peptidylprolyl cis/trans isomerase (Pin1) inhibitors for cancer

    Marine fungi have been proven as potential sources of natural metabolites with significant bioactivities that have not been sufficiently explored....

    Bayan E. Ainousah, Abdulrahim A. Alzain, ... Sabrin R. M. Ibrahim in Mycological Progress
    Article 22 November 2023
  18. Diacylhydrazine Derivatives of 2-(5-(Pyridin-3-yl)-2H-Tetrazol-2-yl)Acetohydrazide and 2-(5-(Pyridin-4-yl)-2H-Tetrazol-2-yl)Acetohydrazide as Potential Inhibitors of Nucleotide Pyrophosphatase

    Abstract

    Nucleotide Pyrophosphatases (NPPs) i.e. NPP1 and 3 are responsible for maintaining the extracellular level of nucleotides and nucleosides and...

    M. Arif, G. Shabir, ... J. Iqbal in Russian Journal of Bioorganic Chemistry
    Article 28 July 2022
  19. Mechanisms of resistance to cyclin-dependent kinase 4/6 inhibitors

    Cyclin-dependent kinase (CDK) 4/6 inhibitors have emerged in the treatment of metastatic hormone receptor (HR)-positive and human epidermal growth...

    Georgia Gomatou, Ioannis Trontzas, ... Elias Kotteas in Molecular Biology Reports
    Article 07 January 2021
  20. ATAC-seq and RNA-seq analysis unravel the mechanism of sex differentiation and infertility in sex reversal chicken

    Background

    Sex determination and differentiation are complex and delicate processes. In female chickens, the process of sex differentiation is...

    **uan Zhang, Jianbo Li, ... Sirui Chen in Epigenetics & Chromatin
    Article Open access 09 January 2023
Did you find what you were looking for? Share feedback.